Although abundant genetic and biochemical evidence strongly links Clusterin (CLU) to Alzheimer disease (AD) pathogenesis, the receptor for CLU within the adult brain is currently unknown. The gene discussed is CLU; the disease is early-onset autosomal dominant Alzheimer disease.